Stockreport

Prevail Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights

Prevail Therapeutics Inc.  (PRVL) 
Last prevail therapeutics inc. earnings: 11/12 09:30 am Check Earnings Report
PDF IND Active for Phase 1/2 Trial of PR001 to Treat Parkinson’s Disease Patients with GBA1 Mutations Successful $125.0 Million Initial Public Offering Completed to Suppo [Read more]